相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz
Leonardo Calza et al.
CURRENT HIV RESEARCH (2016)
A pilot trial of pentoxifylline on endothelial function and inflammation in HIV-infected patients initiating antiretroviral therapy
Samir K. Gupta et al.
AIDS (2016)
Differential CD4+ cell count increase and CD4+: CD8+ ratio normalization with maraviroc compared with tenofovir
Ellen S. Chan et al.
AIDS (2016)
Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection
Theodoros Kelesidis et al.
AIDS (2016)
HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls
Katherine W. Kooij et al.
AIDS (2016)
Monocyte exosomes induce adhesion molecules and cytokines via activation of NF-B in endothelial cells
Norina Tang et al.
FASEB JOURNAL (2016)
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015
Haidong Wang et al.
LANCET (2016)
Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naive to Antiretroviral Therapy: A Pilot Randomized Trial
Sergio Serrano-Villar et al.
PLOS PATHOGENS (2016)
Inflammatory Markers Associated With Subclinical Coronary Artery Disease: The Multicenter AIDS Cohort Study
Hossein Bahrami et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Equivalent Decline in Inflammation Markers with Tenofovir Disoproxil Fumarate vs. Tenofovir Alafenamide
Nicholas T. Funderburg et al.
EBIOMEDICINE (2016)
Monocytes from HIV-infected individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration
Anna Maisa et al.
AIDS (2015)
Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery
Anthony R. Cillo et al.
AIDS (2015)
Risk of cancer among HIV-infected patients from a population-based nested case-control study: implications for cancer prevention
Chang-Hua Chen et al.
BMC CANCER (2015)
Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s
Theodoros Kelesidis et al.
CLINICAL INFECTIOUS DISEASES (2015)
Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation
David A. Zidar et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2015)
Rosuvastatin Reduces Vascular Inflammation and T-cell and Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy
Nicholas T. Funderburg et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2015)
Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061
Bret J. Rudy et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2015)
Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy
Marie R. McCausland et al.
PLOS ONE (2015)
Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized Trial
Steven F. L. van Lelyveld et al.
PLOS ONE (2015)
Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants
Frank J. Palella et al.
AIDS (2014)
Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor-Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1
Jeffrey L. Lennox et al.
ANNALS OF INTERNAL MEDICINE (2014)
Macrophage Inflammatory Markers Are Associated With Subclinical Carotid Artery Disease in Women With Human Immunodeficiency Virus or Hepatitis C Virus Infection
Iftach Shaked et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study
Suhaib Hattab et al.
BMC INFECTIOUS DISEASES (2014)
Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial
J. E. Lake et al.
HIV MEDICINE (2014)
Sevelamer Does Not Decrease Lipopolysaccharide or Soluble CD14 Levels But Decreases Soluble Tissue Factor, Low-Density Lipoprotein (LDL) Cholesterol, and Oxidized LDL Cholesterol Levels in Individuals With Untreated HIV Infection
Netanya G. Sandler et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Lipopolysaccharide, Immune Activation, and Liver Abnormalities in HIV/Hepatitis B Virus (HBV)-Coinfected Individuals Receiving HBV-Active Combination Antiretroviral Therapy
Megan Crane et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results of a randomised, open-label, phase 3b, non-inferiority trial
Jose R. Arribas et al.
LANCET INFECTIOUS DISEASES (2014)
Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week results of a randomised, open-label, phase 3b non-inferiority trial
Anton Pozniak et al.
LANCET INFECTIOUS DISEASES (2014)
Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients
Nicholas T. Funderburg
CURRENT OPINION IN HIV AND AIDS (2014)
Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or treated individuals
Stefania Piconi et al.
AIDS (2013)
Differential penetration of raltegravir throughout gastrointestinal tissue: implications for eradication and cure
Kristine B. Patterson et al.
AIDS (2013)
The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial
Peter W. Hunt et al.
BLOOD (2013)
Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naive, HIV-infected patients (SUPPORT): 96-week results
Princy Kumar et al.
BMC INFECTIOUS DISEASES (2013)
A Randomized Controlled Pilot Trial of Valacyclovir for Attenuating Inflammation and Immune Activation in HIV/Herpes Simplex Virus 2-Coinfected Adults on Suppressive Antiretroviral Therapy
Tae Joon Yi et al.
CLINICAL INFECTIOUS DISEASES (2013)
Decreases in Inflammatory and Coagulation Biomarkers Levels in HIV-Infected Patients Switching from Enfuvirtide to Raltegravir: ANRS 138 Substudy
Erika F. Silva et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada
Hasina Samji et al.
PLOS ONE (2013)
Overcoming pharmacologic sanctuaries
Theodore J. Cory et al.
CURRENT OPINION IN HIV AND AIDS (2013)
HIV Infection and the Risk of Acute Myocardial Infarction
Matthew S. Freiberg et al.
JAMA INTERNAL MEDICINE (2013)
Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir
Grace A. McComsey et al.
AIDS (2012)
Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir
Esteban Martinez et al.
AIDS (2012)
Short Communication Initiation of an Abacavir-Containing Regimen in HIV-Infected Adults Is Associated with a Smaller Decrease in Inflammation and Endothelial Activation Markers Compared to Non-Abacavir-Containing Regimens
Corrilynn O. Hileman et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2012)
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration
Charlotte Lewden et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2012)
Arterial Inflammation in Patients With HIV
Sharath Subramanian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Biomarkers of Microbial Translocation and Macrophage Activation: Association With Progression of Subclinical Atherosclerosis in HIV-1 Infection
Theodoros Kelesidis et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks
Paul E. Sax et al.
LANCET (2012)
Smoking and HIV: Prevalence, Health Risks, and Cessation Strategies
Alan R. Lifson et al.
CURRENT HIV/AIDS REPORTS (2012)
Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy
Duncan Chege et al.
AIDS (2011)
Immunologic Failure Despite Suppressive Antiretroviral Therapy Is Related to Activation and Turnover of Memory CD4 Cells
Michael M. Lederman et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
Netanya G. Sandler et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Salsalate is poorly tolerated and fails to improve endothelial function in virologically suppressed HIV-infected adults
Corrilynn O. Hileman et al.
AIDS (2010)
Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study
Esteban Martinez et al.
AIDS (2010)
Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort study
N. Obel et al.
HIV MEDICINE (2010)
Disruption of Intestinal CD4+ T Cell Homeostasis Is a Key Marker of Systemic CD4+ T Cell Activation in HIV-Infected Individuals
Shari N. Gordon et al.
JOURNAL OF IMMUNOLOGY (2010)
Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection
Jacqueline Neuhaus et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER Study
R. K. Heaton et al.
NEUROLOGY (2010)
Cytomegalovirus-Specific T Cells Persist at Very High Levels during Long-Term Antiretroviral Treatment of HIV Disease
David M. Naeger et al.
PLOS ONE (2010)
Effects of Maraviroc and Efavirenz on Markers of Immune Activation and Inflammation and Associations with CD4+ Cell Rises in HIV-Infected Patients
Nicholas Funderburg et al.
PLOS ONE (2010)
The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in South African HIV-infected individuals
Eefje Jong et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections
Jacob D. Estes et al.
PLOS PATHOGENS (2010)
Exposure to HIV-1 Directly Impairs Mucosal Epithelial Barrier Integrity Allowing Microbial Translocation
Aisha Nazli et al.
PLOS PATHOGENS (2010)
Relationship between Inflammatory Markers, Endothelial Activation Markers, and Carotid Intima-Media Thickness in HIV-Infected Patients Receiving Antiretroviral Therapy
Allison C. Ross et al.
CLINICAL INFECTIOUS DISEASES (2009)
Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen
Todd T. Brown et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Association of C-Reactive Protein and HIV Infection With Acute Myocardial Infarction
Virginia A. Triant et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral-Treated HIV Infection
Wei Jiang et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
HIV-1 RNA Dysregulates the Natural TLR Response to Subclinical Endotoxemia in Kenyan Female Sex-Workers
Richard T. Lester et al.
PLOS ONE (2009)
HIV and antiretroviral therapy: Lipid abnormalities and associated cardiovascular risk in HIV-infected patients
Donald P. Kotler
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy
Tae-Wook Chun et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study:: a multi-cohort collaboration
Caroline A. Sabin et al.
LANCET (2008)
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
LANCET (2008)
Maraviroc for previously treated patients with R5 HIV-1 infection
Roy M. Gulick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
Lewis H. Kuller et al.
PLOS MEDICINE (2008)
MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded toll-like receptor ligands
Angela Meier et al.
JOURNAL OF VIROLOGY (2007)
Class of antiretroviral drugs and the risk of myocardial infarction
Nina Friis-Moller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia
Frank Maldarelli et al.
PLOS PATHOGENS (2007)
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Jason M. Brenchley et al.
NATURE MEDICINE (2006)
Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review
Todd T. Brown et al.
AIDS (2006)
HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir
TW Chun et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the Multicenter AIDS Cohort Study
TT Brown et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
分享论文
